Humacyte (HUMA) Total Debt Growth (1y) (2021 - 2025)
Humacyte (HUMA) Total Debt Growth (1y) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
5.94% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Humacyte |
267.09 Mn |
218.55 Mn |
-1.54 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-66.60% |
| Jun 30, 2025 |
14.09% |
| Mar 31, 2025 |
14.50% |
| Dec 31, 2024 |
68.61% |
| Jun 30, 2024 |
65.74% |
| Mar 31, 2024 |
98.04% |
| Dec 31, 2023 |
350.36% |
| Jun 30, 2023 |
28.85% |
| Mar 31, 2023 |
5.51% |
| Dec 31, 2022 |
-68.67% |
| Sep 30, 2022 |
59.38% |
| Mar 31, 2022 |
277,290.00% |
| Dec 31, 2021 |
735.96% |
| Sep 30, 2021 |
413,536.36% |
